Weiselk Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Weiselk Health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Weiselk Health Today - Breaking & Trending Today

Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma

Published: December 12, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab)...

Source: prnewswire.com

Related Topics:

United StatesGoldschmidth DaratumumabShaji KumarMark WildgustChristie CorbettGlobal Medical AffairsJanssen Biotech IncAmerican Society Of Hematology Annual MeetingJanssen Research DevelopmentJanssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonAmerican Society Of HematologyDivision Of HematologyNational Comprehensive Cancer NetworkAmerican Cancer SocietyNone Of The Janssen Pharmaceutical CompaniesDepartment Of Internal MedicineDrug AdministrationInternational Staging SystemExchange CommissionCompanies Of JohnsonWeiselk HealthAmerican SocietyInternal MedicineVice President